X T L Biopharmaceuticals reported -257000 in Operating Profit for its fourth fiscal quarter of 2020.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Profit Change
Aurinia Pharmaceuticals Inc AUP:CN -47134000 3.41M
Idera Pharmaceuticals IDRA:US $ -5.97M 1.59M
Teva Pharmaceutical TEVA:IT 623M 41M
X T L Biopharmaceuticals XTLB:US -257000 40K
Ziopharm Oncology ZIOP:US $ -22296000 343K